Literature DB >> 6130736

Opioid peptides in the hippocampus: anatomical and physiological considerations.

S J Henriksen, G Chouvet, J McGinty, F E Bloom.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6130736     DOI: 10.1111/j.1749-6632.1982.tb39495.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Systemic phenoxybenzamine but not beta-adrenergic antagonists block noradrenergic inhibition of cerebellar Purkinje and hippocampal pyramidal neurons.

Authors:  D A Staunton; T H Svensson; G E Chouvet; G R Siggins; F E Bloom
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.

Authors:  R Jackisch; M Geppert; A S Brenner; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

3.  The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion.

Authors:  Luca Zangrandi; Johannes Burtscher; James P MacKay; William F Colmers; Christoph Schwarzer
Journal:  Br J Pharmacol       Date:  2016-04-21       Impact factor: 8.739

Review 4.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

5.  Dynorphin-based "release on demand" gene therapy for drug-resistant temporal lobe epilepsy.

Authors:  Alexandra S Agostinho; Mario Mietzsch; Luca Zangrandi; Iwona Kmiec; Anna Mutti; Larissa Kraus; Pawel Fidzinski; Ulf C Schneider; Martin Holtkamp; Regine Heilbronn; Christoph Schwarzer
Journal:  EMBO Mol Med       Date:  2019-09-05       Impact factor: 12.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.